TOR1A Protein — Torsin-1A
Overview
TOR1A (Torsin-1A) is a AAA+ ATPase protein located primarily in the endoplasmic reticulum and nuclear envelope. It is encoded by the [TOR1A](/genes/tor1a) gene and is essential for nuclear envelope and ER organization. Mutations in TOR1A cause early-onset generalized dystonia (DYT1). [@ozelius2020]
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Torsin-1A Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Torsin-1A (TOR1A)</td></tr>
<tr><td><strong>Gene</strong></td><td>[TOR1A](/genes/tor1a)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9UHB6](https://www.uniprot.org/uniprot/Q9UHB6)</td></tr>
<tr><td><strong>PDB Structures</strong></td><td>5J1V, 5J1X, 4TUW</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>38 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Endoplasmic Reticulum, Nuclear Envelope</td></tr>
<tr><td><strong>Protein Family</strong></td><td>AAA+ ATPase family</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Structure
TOR1A is a 332-amino acid protein belonging to the AAA+ (ATPases Associated with diverse cellular Activities) family. The protein contains: [@nery2023]
...TOR1A Protein — Torsin-1A
Overview
TOR1A (Torsin-1A) is a AAA+ ATPase protein located primarily in the endoplasmic reticulum and nuclear envelope. It is encoded by the [TOR1A](/genes/tor1a) gene and is essential for nuclear envelope and ER organization. Mutations in TOR1A cause early-onset generalized dystonia (DYT1). [@ozelius2020]
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Torsin-1A Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Torsin-1A (TOR1A)</td></tr>
<tr><td><strong>Gene</strong></td><td>[TOR1A](/genes/tor1a)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9UHB6](https://www.uniprot.org/uniprot/Q9UHB6)</td></tr>
<tr><td><strong>PDB Structures</strong></td><td>5J1V, 5J1X, 4TUW</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>38 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Endoplasmic Reticulum, Nuclear Envelope</td></tr>
<tr><td><strong>Protein Family</strong></td><td>AAA+ ATPase family</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Structure
TOR1A is a 332-amino acid protein belonging to the AAA+ (ATPases Associated with diverse cellular Activities) family. The protein contains: [@nery2023]
- N-terminal transmembrane domain that anchors it to the ER membrane
- Central AAA+ ATPase domain that hydrolyzes ATP to generate mechanical force
- C-terminal domain involved in protein interactions and cofactor binding
The AAA+ domain adopts a characteristic Rossmann-like fold with Walker A (P-loop) and Walker B motifs essential for ATP binding and hydrolysis. The protein forms hexameric ring structures that exert force on substrates.
Mermaid diagram (expand to render)
Function
Nuclear Envelope Dynamics
TOR1A participates in nuclear envelope reformation during mitosis and helps maintain nuclear envelope integrity. It localizes to the inner nuclear membrane and interacts with nuclear pore complex proteins including NUP153 and NUP98. [@gonzalezalegre2019]
The protein facilitates the removal of mislocalized inner nuclear membrane proteins and helps reshape the envelope during nuclear envelope breakdown and reassembly in cell division.
ER Homeostasis and Quality Control
The protein is involved in ER quality control processes, including the degradation of misfolded proteins through the [ERAD pathway](/mechanisms/endoplasmic-reticulum-stress). TOR1A interacts with SEL1L and OS-9, key components of the ERAD machinery.
TOR1A has been implicated in lipid droplet formation and distribution, suggesting roles in cellular energy homeostasis. It localizes to lipid droplet surfaces and may regulate lipase access to stored triglycerides.
Interaction with Nuclear Envelope Proteins
| Partner Protein | Interaction Type | Functional Consequence |
|----------------|-----------------|------------------------|
| LAP1 (Lamina-associated polypeptide 1) | Direct binding | NE organization |
| MAN1 (MAN1 domain containing 1) | Direct binding | Nuclear envelope integrity |
| NUP153 | Direct binding | Nuclear pore function |
| YB-1 (YBX1) | Direct binding | mRNA export regulation |
Role in Neurodegeneration
Dystonia (DYT1)
The most well-established link between TOR1A and disease is autosomal dominant early-onset generalized dystonia (DYT1). The most common mutation is a deletion of a glutamic acid (E302/303, also written as ΔE302/303) in the protein, which disrupts its ATPase activity and leads to abnormal protein aggregation. [@kawarai2016]
Mechanism of DYT1 dystonia:
The E302/303 deletion reduces TOR1A ATPase activity by ~50%
Impaired ATP hydrolysis leads to defective protein unfolding
Mutant TOR1A forms cytoplasmic inclusions in neurons
These inclusions disrupt normal neuronal function
Results in involuntary muscle contractions and abnormal posturesParkinson's Disease
Some studies have suggested potential connections between TOR1A variants and PD risk, though the evidence is less conclusive. The protein's role in ER stress response may be relevant to [alpha-synuclein](/proteins/alpha-synuclein) toxicity. [@hettich2020]
Potential PD connections:
- ER stress response overlaps with [alpha-synuclein](/proteins/alpha-synuclein) pathology
- Nuclear envelope abnormalities in dopaminergic neurons
- Potential interactions with [PARKIN](/proteins/parkin-protein) and [PINK1](/proteins/pink1-protein) mitophagy pathways
- Lipid droplet accumulation in PD models
Neuroimaging Findings
Studies in DYT1 carriers have revealed: [@niccolini2015]
- Reduced binding in the pallidum and substantia nigra on PET
- Abnormal motor cortex excitability
- Altered connectivity in basal ganglia circuits
Animal Models
Several animal models have been developed to study DYT1 dystonia: [@ledoux2019]
- Tor1a knock-in mice: Express the E302/303 deletion, show subtle motor phenotypes
- Tor1a conditional knockouts: Neuron-specific deletion causes more severe phenotypes
- Drosophila TOR1A homolog: Loss of function causes developmental defects
- Transgenic rat models: Express mutant human TOR1A, show dystonic phenotypes
Therapeutic Implications
Gene Therapy Approaches
- AAV-mediated TOR1A expression: Wild-type TOR1A delivery to restore function
- Allele-specific silencing: siRNA targeting mutant allele only
- CRISPR editing: Correct the E302/303 deletion mutation
Small Molecule Modulators
- Targeting TOR1A ATPase activity: Develop activators to compensate for reduced function
- Protein-folding interventions: Enhance proper TOR1A folding and function
- Chaperone-based therapies: Promote correct protein conformation
Symptomatic Treatments
- Deep brain stimulation: GPi targeting for severe dystonia
- Botulinum toxin injections: For focal dystonias
- Anticholinergic medications: Trihexyphenidyl, baclofen
Cross-linking to Neurodegeneration Pathways
- [Dystonia](/diseases/dystonia) - Primary disease
- [Parkinson's Disease](/diseases/parkinsons-disease) - Potential connection
- [Endoplasmic Reticulum Stress](/mechanisms/endoplasmic-reticulum-stress) - ERAD pathway
- [Nuclear Envelope](/mechanisms/nuclear-envelope) - NE dynamics
- [Alpha-Synuclein](/proteins/alpha-synuclein) - Potential aggregation link
- [Unfolded Protein Response](/entities/unfolded-protein-response) - ER stress response
- [PINK1-PARKIN Pathway](/mechanisms/pink1-parkin-mitophagy-pathway-parkinsons) - Mitochondrial quality control
- [ERAD Pathway](/mechanisms/endoplasmic-reticulum-associated-degradation) - Protein quality control
See Also
- [Dystonia](/diseases/dystonia)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Endoplasmic Reticulum Stress](/mechanisms/endoplasmic-reticulum-stress)
- [Nuclear Envelope](/mechanisms/nuclear-envelope)
- [TOR1A Gene](/genes/tor1a)
External Links
- [UniProt: TOR1A Human](https://www.uniprot.org/uniprotkb/Q9UHB6)
- [Gene: TOR1A - NCBI](https://www.ncbi.nlm.nih.gov/gene/60180)
- [PDB: TOR1A Structure](https://www.rcsb.org/structure/5J1V)
- [OMIM: DYT1 Dystonia](https://www.omim.org/entry/128100)
References
[Ozelius LJ et al, The TOR1A (DYT1) gene product: A target for dystonia therapy (2020)](https://pubmed.ncbi.nlm.nih.gov/32766963/)
[Nery FC et al, TorsinA and the nuclear envelope (2023)](https://pubmed.ncbi.nlm.nih.gov/36847215/)
[Gonzalez-Alegre P, Molecular pathways involved in neurodegeneration in DYT1 dystonia (2019)](https://pubmed.ncbi.nlm.nih.gov/31487567/)
[Kawarai T et al, Motor cortex hyperexcitability in DYT1 dystonia (2016)](https://pubmed.ncbi.nlm.nih.gov/27265680/)
[Niccolini F et al, Dystonia in DYT1 knock-in mice (2015)](https://pubmed.ncbi.nlm.nih.gov/25511707/)
[Ledoux MS et al, Animal models of DYT1 dystonia (2019)](https://pubmed.ncbi.nlm.nih.gov/30769120/)
[Hettich J et al, TorsinA and the unfolded protein response (2020)](https://pubmed.ncbi.nlm.nih.gov/32802812/)